National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

temsirolimusPatient Information
An ester analog of rapamycin. Temsirolimus binds to and inhibits the mammalian target of rapamycin (mTOR), resulting in decreased expression of mRNAs necessary for cell cycle progression and arresting cells in the G1 phase of the cell cycle. mTOR is a serine/threonine kinase which plays a role in the PI3K/AKT pathway that is upregulated in some tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:cell cycle inhibitor 779
rapamycin analog CCI-779
US brand name:Torisel
Code name:CCI-779
Chemical structure name:42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin



Previous:telomerase: 540-548 peptide vaccine, teloxantrone hydrochoride, Temodar, temozolomide, Tempostatin
Next:teniposide, tenofovir, terameprocol, terephthalamidine, teroxirone

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov